Skip to main content
. Author manuscript; available in PMC: 2006 Jul 1.
Published in final edited form as: Cancer Gene Ther. 2006 Feb 24;13(7):648–657. doi: 10.1038/sj.cgt.7700943

Figure 7.

Figure 7

Tumor size and weight of mice treated with a combination of PE38 packaged in vitro and doxorubicin via IP. Treatment was followed three days after inoculation of mice with 2 × 106 KB-3-1 cells. Tumor size as well as the weight of the mice were followed for 56 days. Figure 6a demonstrates average tumor size in mm3 of IVP-PE-treated mice (blue), doxorubicin-treated mice (orange), and the combined treatment of IVP-PE38 with 5 mg/kg doxorubicin-treated mice (green) (five mice in each group). Panel b is the average weight of each of these groups with standard deviations (z = (−1.8991), one sided p-value = 0.0288 on day 40 of treatment with doxorubicin in comparison to the combination of doxorubicin and IVP-PE38)